BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9330847)

  • 1. Hypericin inhibits choroidal endothelial cell proliferation and cord formation in vitro.
    Kimura H; Harris MS; Sakamoto T; Gopalakrishna R; Gundimeda U; Cui JZ; Spee C; Hinton DR; Ryan SJ
    Curr Eye Res; 1997 Oct; 16(10):967-72. PubMed ID: 9330847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C.
    Harris MS; Sakamoto T; Kimura H; He S; Spee C; Gopalakrishna R; Gundimeda U; Yoo JS; Hinton DR; Ryan SJ
    Curr Eye Res; 1996 Mar; 15(3):255-62. PubMed ID: 8654105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericin: a potential antiglioma therapy.
    Couldwell WT; Gopalakrishna R; Hinton DR; He S; Weiss MH; Law RE; Apuzzo ML; Law RE
    Neurosurgery; 1994 Oct; 35(4):705-9; discussion 709-10. PubMed ID: 7808614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S; Takagi H; Otani A; Suzuma K; Nishimura K; Honda Y
    Br J Pharmacol; 1999 May; 127(2):537-45. PubMed ID: 10385256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutrophil superoxide generation by hypericin, an antiretroviral agent.
    Nishiuchi T; Utsumi T; Kanno T; Takehara Y; Kobuchi H; Yoshioka T; Horton AA; Yasuda T; Utsumi K
    Arch Biochem Biophys; 1995 Nov; 323(2):335-42. PubMed ID: 7487096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypericin in the dark inhibits key steps of angiogenesis in vitro.
    Martínez-Poveda B; Quesada AR; Medina MA
    Eur J Pharmacol; 2005 Jun; 516(2):97-103. PubMed ID: 15921677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
    Takeda A; Hata Y; Shiose S; Sassa Y; Honda M; Fujisawa K; Sakamoto T; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):765-72. PubMed ID: 12937991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria.
    Miccoli L; Beurdeley-Thomas A; De Pinieux G; Sureau F; Oudard S; Dutrillaux B; Poupon MF
    Cancer Res; 1998 Dec; 58(24):5777-86. PubMed ID: 9865736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C.
    Zhang W; Lawa RE; Hintona DR; Su Y; Couldwell WT
    Cancer Lett; 1995 Sep; 96(1):31-5. PubMed ID: 7553605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of fibroblast growth factor-5 by bovine choroidal endothelial cells in vitro.
    Keithahn MA; Aotaki-Keen AE; Schneeberger SA; Hjelmeland LM; Morse LS
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2073-80. PubMed ID: 9331271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-induced photoactivation of hypericin inhibits cellular growth in pituitary adenoma cell line AtT20/D16v-F2 (hypericin inhibits cellular growth of AtT20/D16v-F2).
    Mareková M; Vávrová J; Vokurková D; Cerman J
    Acta Medica (Hradec Kralove); 2001; 44(1):7-13. PubMed ID: 11367893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells.
    Sakamoto T; Sakamoto H; Murphy TL; Spee C; Soriano D; Ishibashi T; Hinton DR; Ryan SJ
    Arch Ophthalmol; 1995 Apr; 113(4):512-20. PubMed ID: 7536000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.
    Zhang W; Law RE; Hinton DR; Couldwell WT
    Cancer Lett; 1997 Nov; 120(1):31-8. PubMed ID: 9570383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro.
    Zhang W; Anker L; Law RE; Hinton DR; Gopalakrishna R; Pu Q; Gundimeda U; Weiss MH; Couldwell WT
    Clin Cancer Res; 1996 May; 2(5):843-6. PubMed ID: 9816239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application.
    Hamilton HB; Hinton DR; Law RE; Gopalakrishna R; Su YZ; Chen ZH; Weiss MH; Couldwell WT
    J Neurosurg; 1996 Aug; 85(2):329-34. PubMed ID: 8755764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic inactivation of radiation leukemia virus produced from hypericin-treated cells.
    Degar S; Lavie G; Meruelo D
    Virology; 1993 Dec; 197(2):796-800. PubMed ID: 7504371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.
    Hwang MS; Yum YN; Joo JH; Kim S; Lee KK; Gee SW; Kang HI; Kim OH
    Anticancer Res; 2001; 21(4A):2649-55. PubMed ID: 11724334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells.
    Wang YS; Friedrichs U; Eichler W; Hoffmann S; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2002 Jan; 240(1):42-8. PubMed ID: 11954780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.